# The Misuse of Drugs (Amendment) Regulations (Northern Ireland) 2021, Regulation 2: Amendment of the Misuse of Drugs Regulations (Northern Ireland) 2002


(1) The following amendments are made to Schedule 1 to the Misuse of Drugs Regulations (Northern Ireland) 2002 (which specifies controlled drugs that are subject to the requirements of regulations 14, 15, 16, 18, 19, 20, 23, 26 and 27 of those Regulations).
(2) In paragraph 1(a)—
(a) after “Etryptamine” insert “Flualprazolam (8-chloro-6-(2-fluorophenyl)-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine)”;
(b) after “Flubromazolam (8-Bromo-6-(2-fluorophenyl)-1-methyl-4H -[1,2,4]triazolo[4,3-a][1,4] benzodiazepine)” insert “Flunitrazolam (6-(2-fluorophenyl)-1-methyl-8-nitro-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine)”;
(c) after “Nitrazolam (1-Methyl-8-nitro-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine)” insert “Norfludiazepam (7-chloro-5-(2-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one)”.

---
Source: https://www.legislation.gov.uk/nisr/2021/221/regulation/2 (the official version)
Page: https://openlegislation.uk/misuse-of-drugs-amendment-regulations-northern-ireland-2021/regulation-2
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.